Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group-Reference-Cited by-同舟云学术

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group

Published:2018-03 Issue:3 Volume:8 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Katodritou Eirini,Terpos Evangelos,Delimpasi Sossana,Kotsopoulou Maria,Michalis Eurydiki,Vadikolia Chrysanthi,Kyrtsonis Marie-Christine,Symeonidis Argiris,Giannakoulas Nikolaos,Vadikolia Chrissa,Michael Michalis,Kalpadakis Christina,Gougopoulou Theodora,Prokopiou Chrystalla,Kaiafa Georgia,Christoulas Dimitrios,Gavriatopoulou Maria,Giannopoulou Evlampia,Labropoulou Vasiliki,Verrou Evgenia,Kastritis Efstathios^ORCID,Konstantinidou Pavlina,Anagnostopoulos Achilles,Dimopoulos Meletios A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-018-0059-6.pdf

Reference25 articles.

1. Bladé, J. & Kyle, R. A. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol. Oncol. Clin. North Am. 13, 1259–1272 (1999).

2. IMWG. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br. J. Haematol. 121, 749–757 (2003).

3. Kyle, R. A., Maldonado, J. E. & Bayrd, E. D. Plasma cell leukemia. Report on 17 cases. Arch. Intern Med. 133, 813–818 (1974).

4. Fernández de Larrea, C. et al. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia 27, 780–791 (2013).

5. Musto, P., Simeon, V., Todoerti, K. & Neri, A. Primary Plasma cell leukemia: Identity card 2016. Curr. Treat. Options Oncol. 17, 19 (2016).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study;Annals of Hematology;2024-07-29

2. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study;Hematology;2023-09-21

3. Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma;Journal of Clinical Oncology;2023-08-10

4. Sequential autologous and allogeneic stem cell transplantation for treatment of primary plasma cell leukemia: A case report;Molecular and Clinical Oncology;2023-08-02

5. Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group;American Journal of Hematology;2023-03-16